Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
27.86
+0.78 (2.88%)
Jul 10, 2025, 12:04 PM - Market open
Veracyte Stock Forecast
Stock Price Forecast
The 9 analysts that cover Veracyte stock have a consensus rating of "Buy" and an average price target of $39.89, which forecasts a 43.18% increase in the stock price over the next year. The lowest target is $28 and the highest is $45.
Price Target: $39.89 (+43.18%)
Analyst Consensus: Buy
* Price targets were last updated on May 8, 2025.
Analyst Ratings
The average analyst rating for Veracyte stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $49 → $42 | Strong Buy | Maintains | $49 → $42 | +50.75% | May 8, 2025 |
| Needham | Needham | Strong Buy Maintains $51 → $41 | Strong Buy | Maintains | $51 → $41 | +47.16% | May 8, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $45 → $37 | Strong Buy | Maintains | $45 → $37 | +32.81% | Apr 9, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $45 | Buy | Reiterates | $45 | +61.52% | Mar 26, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +61.52% | Mar 20, 2025 |
Financial Forecast
Revenue This Year
501.36M
from 445.76M
Increased by 12.47%
Revenue Next Year
549.83M
from 501.36M
Increased by 9.67%
EPS This Year
0.52
from 0.31
Increased by 67.26%
EPS Next Year
0.71
from 0.52
Increased by 36.72%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 522.7M | 585.8M | 646.5M | ||
| Avg | 501.4M | 549.8M | 598.7M | ||
| Low | 472.5M | 498.5M | 533.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.3% | 16.8% | 17.6% | ||
| Avg | 12.5% | 9.7% | 8.9% | ||
| Low | 6.0% | -0.6% | -3.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.68 | 0.95 | 1.24 | ||
| Avg | 0.52 | 0.71 | 0.89 | ||
| Low | 0.38 | 0.27 | 0.47 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 120.2% | 82.3% | 74.8% | ||
| Avg | 67.3% | 36.7% | 25.7% | ||
| Low | 23.3% | -47.1% | -33.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.